Celadon Pharmaceuticals

Board Committees

The Company has established Audit, Nomination and Remuneration Committees.

The Audit Committee has David Firth as chairman, and has primary responsibility for monitoring the quality of internal controls, ensuring that the financial performance of the Group is properly measured and reported on and reviewing reports from the Group’s auditors relating to the Group’s accounting and internal controls, in all cases having due regard to the interests of Shareholders. The Audit Committee meets at least two times a year. Elizabeth Shanahan and Robert Barr are the other members of the Audit Committee.

The Nomination Committee has Alexander Anton as chairman, and identifies and nominates, for the approval of the Board, candidates to fill board vacancies as and when they arise. The Nomination Committee meets at least once a year. Elizabeth Shanahan and Robert Barr are the other members of the Nomination Committee.

The Remuneration Committee has David Firth as chairman, and reviews the performance of the executive directors and determine their terms and conditions of service, including their remuneration and the grant of options, having due regard to the interests of Shareholders. The Remuneration Committee meets at least twice a year. Robert Barr and Alexander Anton are the other members of the Remuneration Committee.